preparation and evaluation of 2-(allythio)pyrazine-loaded lipid emulsion with enhanced stability and liver targeting
최한곤, 성정훈, 김종국, 장준희
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2009
382
Preparation and Evaluation of 2-(Allylthio)Pyrazine-Loaded Lipid Emulsion with Enhanced Stability and Liver Targeting
최한곤, Jun-Hee Jang, Jung Hoon Sung, Chong-Kook Kim
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2009
383
Cationic derivatives of biocompatible hyaluronic acids for deliverty of siRNA and antisense of oligonucleotides
최한곤, 오유경, 한수은, 심가영, 김성재, 강현구, 김지석, 한세광
JOURNAL OF DRUG TARGETING, 2009
384
Cationic derivatives of biocompatible hyaluronic acids for delivery of siRNA and antisense oligonucleotides
최한곤, SU-EUN HAN, HYUNGU KANG, GA YONG SHIM, SUN JAE KIM, JI SEOK KIM, SEI KWANG HAHN, YU-KYOUNG OH
JOURNAL OF DRUG TARGETING, 2009
385
Opsonized erythrocyte ghosts for liver-targeted delivery of antisense oligodeoxynucleotides
최한곤, Sang-Hee Kim, Eun-Joong Kim, Joon-Hyuk Hou, Jung-Mogg Kim, Chang-Koo Shim, Yu-Kyoung Oh
BIOMATERIALS, 2009
386
Development of nifedipine-loaded coated gelatin microcapsule as a long acting oral delivery
최한곤, Dong Xun Li, Jong Oh Kim, Dong Hoon Oh, Won Seok Lee, Myung Ja Hong, Jin Yang Kang, Jong Seo Choi, Jong Soo Woo, Chul Soon Yong
ARCHIVES OF PHARMACAL RESEARCH, 2009
387
Toxicity studies of cremophor-free paclitaxel solid dispersion formulated by a supercritical antisolvent process
최한곤, Jae-Hyun Park, Sang-Cheol Chi, Won Seok Lee, Won Mo Lee, Yoon Bon Koo, Chul Soon Yong, Jong Soo Woo
ARCHIVES OF PHARMACAL RESEARCH, 2009
388
Development of Clindamycin-Loaded Wound Dressing with Polyvinyl Alcohol and Sodium Alginate
최한곤, Jong Oh KIM, Jun Young CHOI, Jung Kil PARK, Jeong Hoon KIM, Sung Giu JIN, Sun Woo CHANG, Dong Xun LI, Ma-Ro Hwang, Jong Soo WOO, Jung-Ae KIM, Won Seok LYOO, Chul Soon YONG
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008
389
Skin penetration and retention of L-Ascorbic acid 2-phosphate using multilamellar vesicles
최한곤, Yoo J, Shanmugam S, Song CK, Kim DD, Yong CS, Woo JS, Yoo BK
ARCHIVES OF PHARMACAL RESEARCH, 2008
390
Clotrimazole ameliorates intestinal inflammation and abnormal angiogenesis by inhibiting IL-8 expression through a NF-{kappa}B-dependent manner